Network pharmacology integrated molecular docking reveals the potential of Hypericum japonicum Thunb. ex Murray against COVID-19

Network pharmacology integrated molecular docking reveals the potential of Hypericum japonicum Thunb. ex Murray against COVID-19

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). However, there are still no specific treatments. Recently, traditional Chinese medicine (TCM) was proposed as a potential therapeutic strategy for the pre...

Full description

Bibliographic Details
Main Authors: Weiwei Su, Pan Chen, Zifeng Yang, Nanshan Zhong, Qinhai Ma, Xuan Zeng, Jiashuo Zhang, Yonggang Wang, Peibo Li
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
hypericum japonicum
covid-19
network pharmacology
molecular docking
Online Access:http://dx.doi.org/10.1080/13102818.2021.1886873

Internet

http://dx.doi.org/10.1080/13102818.2021.1886873

Similar Items